查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1970815

全球自動化乳房超音波系統市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Automated Breast Ultrasound Systems Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 110 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計到 2034 年，自動乳房超音波系統市場規模將從 2025 年的 29.7 億美元成長至 96.9 億美元，2026 年至 2034 年的複合年成長率為 14.06%。

隨著對早期癌症檢測和先進診斷成像的需求不斷成長，全球自動化乳房超音波（ABUS）市場預計將持續擴張。 ABUS作為乳房X光攝影的補充手段，正日益受到重視，尤其適用於乳房組織緻密的女性，因為傳統影像方法可能不足以滿足她們的需求。高解析度3D成像、自動化掃描通訊協定和基於人工智慧的解讀工具的整合，提高了診斷的可靠性，並降低了操作者差異。

由於其高效性、縮短的檢查時間和高患者處理能力，醫療機構正優先考慮自動乳房超音波（ABUS）解決方案。超音波換能器技術、影像重建演算法和使用者友善介面的不斷改進，正推動醫院、診斷中心和乳房護理診所的臨床應用不斷擴展。自動化、雲端資料儲存和遠端醫療平台的結合，進一步擴大了已開發市場和新興市場獲得先進診斷影像服務的機會。

展望未來，基於深度學習的檢測演算法的進步、與磁振造影（MRI）和數位乳房X光攝影的多重模式融合以及即時4D成像技術有望將自動乳房超音波（ABUS）的診斷準確率提升到一個新的水平。公共篩檢計畫的擴展、預防醫學意識提升以及個人化醫療的推廣等趨勢也有望促進市場成長。結合技術創新和全球衛生政策，ABUS將繼續成為降低全球乳癌死亡率的核心工具。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球自動化乳房超音波系統市場：依產品分類

  • 市場分析、洞察與預測
  • 自動乳房容積掃描儀
  • 自動乳房超音波系統（ABUS）

第5章：全球自動化乳房超音波系統市場：依最終用途分類

  • 市場分析、洞察與預測
  • 醫院
  • 診斷影像檢查實驗室
  • 其他

第6章 全球自動化乳房超音波系統市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第7章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第8章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • GE HealthCare
    • Koninklijke Philips NV
    • Siemens Healthcare Private Limited
    • Canon Medical Systems Corporation
    • Telemed Medical Systems Srl
    • Hologic Inc
    • SuperSonic Imagine
    • Lunit Inc
    • Delphinus Medical Technologies Inc
簡介目錄
Product Code: VMR112111348

The Automated Breast Ultrasound Systems Market size is expected to reach USD 9.69 Billion in 2034 from USD 2.97 Billion (2025) growing at a CAGR of 14.06% during 2026-2034.

The global automated breast ultrasound systems (ABUS) market is positioned for expansion as demand for early cancer detection and advanced diagnostic imaging grows. ABUS is increasingly being deployed as a complementary modality to mammography, particularly for women with dense breast tissue where conventional imaging may lack accuracy. Integration of high-resolution 3D imaging, automated scanning protocols, and AI-based interpretation tools is enhancing diagnostic confidence and reducing inter-operator variability.

Healthcare providers are prioritizing ABUS solutions for their efficiency, reduced examination time, and capability to handle high patient throughput. Continuous improvements in ultrasound transducer technology, image reconstruction algorithms, and user-friendly interfaces are expanding clinical adoption across hospitals, diagnostic centers, and breast care clinics. The combination of automation with cloud-based data storage and telemedicine platforms is further broadening access to advanced imaging in both developed and emerging markets.

Looking forward, advances in deep learning-based detection algorithms, multi-modality integration with MRI and digital mammography, and real-time 4D imaging will elevate ABUS to the next level of diagnostic precision. The market is expected to benefit from public screening programs, rising awareness of preventive healthcare, and the ongoing push for personalized medicine. With technological innovation and global health initiatives converging, ABUS will remain a pivotal tool in reducing breast cancer mortality rates worldwide.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

  • Automated Breast Volume Scanner
  • Automated Breast Ultrasound (ABUS)

By End Use

  • Hospital
  • Diagnostics Imaging Laboratories
  • Others

COMPANIES PROFILED

  • GE HealthCare, Koninklijke Philips NV, Siemens Healthcare Private Limited, Canon Medical Systems Corporation, Telemed Medical Systems srl, Hologic Inc, SuperSonic Imagine, Lunit Inc, Delphinus Medical Technologies Inc
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL AUTOMATED BREAST ULTRASOUND SYSTEMS MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Automated Breast Volume Scanner Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Automated Breast Ultrasound (ABUS) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL AUTOMATED BREAST ULTRASOUND SYSTEMS MARKET: BY END USE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast End Use
  • 5.2. Hospital Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Diagnostics Imaging Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL AUTOMATED BREAST ULTRASOUND SYSTEMS MARKET: BY REGION 2022-2034(USD MN)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.2.1 By Product
    • 6.2.2 By End Use
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.3.1 By Product
    • 6.3.2 By End Use
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Russia
    • 6.3.8 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.4.1 By Product
    • 6.4.2 By End Use
    • 6.4.3 India
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 Australia
    • 6.4.7 South East Asia
    • 6.4.8 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.5.1 By Product
    • 6.5.2 By End Use
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 South East Asia
    • 6.5.8 Rest of Latin America
  • 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.6.1 By Product
    • 6.6.2 By End Use
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain & Channel Partners (based on availability)
  • 7.4. Market Share & Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL AUTOMATED BREAST ULTRASOUND SYSTEMS INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 GE HealthCare
    • 8.2.2 Koninklijke Philips N.V
    • 8.2.3 Siemens Healthcare Private Limited
    • 8.2.4 Canon Medical Systems Corporation
    • 8.2.5 Telemed Medical Systems Srl
    • 8.2.6 Hologic Inc
    • 8.2.7 SuperSonic Imagine
    • 8.2.8 Lunit Inc
    • 8.2.9 Delphinus Medical Technologies Inc